Back/Pioneer Power Solutions: Radiance Technologies Advances Biomanufacturing with DARPA's MICA Program
biotech·October 11, 2025·ppsi

Pioneer Power Solutions: Radiance Technologies Advances Biomanufacturing with DARPA's MICA Program

ED
Editorial
Cashu Markets·3 min read
TL;DR
  • Radiance Technologies is leading biomanufacturing innovation through DARPA's MICA program, focusing on advanced microsystems and protein control.
  • The MICA initiative aims to enhance biomanufacturing efficiency by integrating various physical factors for molecular-level chemical reactions.
  • Radiance’s collaboration with LA Tech strengthens research and positions North Louisiana as a growing biotechnology hub.

Innovations in Biomanufacturing: Radiance Technologies Takes the Lead

Radiance Technologies, an employee-owned leader in defense and intelligence innovation, is making significant strides in the field of biomanufacturing through a new contract awarded by the Defense Advanced Research Projects Agency (DARPA). This contract is part of the Microsystem Induced Catalytic Activity (MICA) program, which aims to develop advanced microsystems capable of precisely controlling protein functions. This initiative holds considerable promise for applications across biomanufacturing, national security, and medical fields. The partnership with Louisiana Tech University (LA Tech) enhances the program’s potential, combining Radiance's strengths in defense technology with LA Tech's expertise in nanotechnology and computational biology.

At the heart of the MICA program is the Adaptive Multi-Physics Engine for Reaction Engineering (AMPERE), an innovative simulation platform that integrates machine learning with multi-scale physical modeling. This cutting-edge technology predicts the behaviors of biomolecular catalysts when subjected to microsystem stimulation. Dr. Andrew Gardner, the Principal Investigator for MICA at Radiance, notes that this program is essential for bridging the gap between molecular-scale biological control and scalable microsystem design. The outcomes of MICA are expected to facilitate the development of advanced therapeutics and resilient biomanufacturing processes, marking a significant advancement in the field.

The MICA initiative also seeks to explore the integration of various physical factors—such as heat, electromagnetic fields, and fluid motion—to guide molecular-level chemical reactions. By designing systems that align seamlessly with biological processes, the program aims to enhance the efficiency and efficacy of biomanufacturing techniques. This contract builds upon Radiance's previous collaboration with LA Tech and LSU Health Shreveport under DARPA's Simulating Microbial Systems (SMS) program, which focuses on developing predictive models of microbial behavior. Bill Bailey, CEO of Radiance Technologies, emphasizes the importance of both MICA and SMS programs in fostering bioengineering innovation, particularly highlighting North Louisiana's emerging position as a hub for biotechnology.

In addition to its groundbreaking work with the MICA program, Radiance Technologies continues to enhance national capabilities and support research excellence. Founded in 1999, the company remains committed to leveraging its innovative technologies to meet the evolving needs of defense and intelligence sectors. The collaboration with LA Tech not only strengthens research efforts but also contributes to the region’s economic growth and technological advancements.

The developments in the MICA program underscore the vital intersection of biotechnology and defense innovation, showcasing how cutting-edge research can lead to transformative applications across multiple industries. Radiance Technologies is poised to make a substantial impact in biomanufacturing, setting the stage for future advancements that could redefine the landscape of therapeutic development and production.